person
as of 2026-07-01George Haig, PharmD
at a glance
Roles: Study Director
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
AbbVie
Roles
Study Director
Trial investigator
no
Trials led
5
A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia
NCT01678755Phase 2Completed
A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia
NCT01655680Phase 2Completed
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
NCT01077700Phase 2Completed
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
NCT01095562Phase 2Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
STUDY_DIRECTOR